Gossamer Bio, Inc. (GOSS)
3.435
+0.15
(+4.57%)
USD |
NASDAQ |
Dec 24, 12:59
3.46
+0.02
(+0.73%)
After-Hours: 13:59
Gossamer Bio SG&A Expense (TTM): 36.12M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| XOMA Royalty Corp. | 32.68M |
| Rezolute, Inc. | 20.85M |
| PepGen Inc. | 22.10M |
| NovaBay Pharmaceuticals, Inc. | 8.584M |
| Palatin Technologies, Inc. | 7.449M |